Niagen Bioscience (NAGE) came out with quarterly earnings of $0.05 per share, beating the Zacks Consensus Estimate of $0.02 per share. This compares to earnings of $0.02 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of +150.00%. A quarter ago, it was expected that this natural products company would post earnings of $0.02 per share when it actually produced earnings of $0.04, delivering a surprise of +100%.Over the last four qu ...

Stoke Therapeutics, Inc. (STOK) came out with a quarterly loss of $0.65 per share versus the Zacks Consensus Estimate of a loss of $0.54. This compares to a loss of $0.47 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of -20.37%. A quarter ago, it was expected that this company would post a loss of $0.57 per share when it actually produced a loss of $0.4, delivering a surprise of +29.82%.Over the last four quarters, the company ...

Exelixis (EXEL) came out with quarterly earnings of $0.78 per share, beating the Zacks Consensus Estimate of $0.68 per share. This compares to earnings of $0.47 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of +14.71%. A quarter ago, it was expected that this drug developer would post earnings of $0.65 per share when it actually produced earnings of $0.75, delivering a surprise of +15.38%.Over the last four quarters, the compan ...

Tarsus Pharmaceuticals, Inc. (TARS) came out with a quarterly loss of $0.3 per share versus the Zacks Consensus Estimate of a loss of $0.35. This compares to a loss of $0.61 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of +14.29%. A quarter ago, it was expected that this company would post a loss of $0.33 per share when it actually produced a loss of $0.48, delivering a surprise of -45.45%.Over the last four quarters, the comp ...

PTC Therapeutics (PTCT) came out with quarterly earnings of $0.2 per share, beating the Zacks Consensus Estimate of a loss of $1.19 per share. This compares to a loss of $1.39 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of +116.81%. A quarter ago, it was expected that this biopharmaceutical company would post a loss of $1.07 per share when it actually produced a loss of $0.83, delivering a surprise of +22.43%.Over the last fo ...

Amgen (AMGN) came out with quarterly earnings of $5.64 per share, beating the Zacks Consensus Estimate of $5 per share. This compares to earnings of $5.58 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of +12.80%. A quarter ago, it was expected that this world's largest biotech drugmaker would post earnings of $5.26 per share when it actually produced earnings of $6.02, delivering a surprise of +14.45%.Over the last four quarter ...

Day One Biopharmaceuticals, Inc. (DAWN) came out with a quarterly loss of $0.19 per share versus the Zacks Consensus Estimate of a loss of $0.28. This compares to earnings of $0.38 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of +32.14%. A quarter ago, it was expected that this company would post a loss of $0.35 per share when it actually produced a loss of $0.29, delivering a surprise of +17.14%.Over the last four quarters, t ...

Mirum Pharmaceuticals, Inc. (MIRM) came out with quarterly earnings of $0.05 per share, beating the Zacks Consensus Estimate of a loss of $0.1 per share. This compares to a loss of $0.3 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of +150.00%. A quarter ago, it was expected that this company would post a loss of $0.31 per share when it actually produced a loss of $0.12, delivering a surprise of +61.29%.Over the last four quart ...

Qiagen (QGEN) came out with quarterly earnings of $0.61 per share, beating the Zacks Consensus Estimate of $0.58 per share. This compares to earnings of $0.59 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of +5.17%. A quarter ago, it was expected that this diagnostic products maker would post earnings of $0.6 per share when it actually produced earnings of $0.6, delivering no surprise.Over the last four quarters, the company ha ...

Tango Therapeutics, Inc. (TNGX) came out with quarterly earnings of $0.13 per share, beating the Zacks Consensus Estimate of $0.01 per share. This compares to a loss of $0.27 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of +1,200.00%. A quarter ago, it was expected that this company would post a loss of $0.35 per share when it actually produced a loss of $0.35, delivering no surprise.Over the last four quarters, the company ha ...